Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088. doi: 10.1210/jc.2018-01865.

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Author information

1
Cohen Children's Medical Center of New York, New York, New York.
2
Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
3
University of Birmingham, Birmingham, United Kingdom.
4
University of Michigan, Ann Arbor, Michigan.
5
University of California San Francisco, San Francisco, California.
6
University College London Hospitals, London, United Kingdom.
7
National Institutes of Health Clinical Center, Bethesda, Maryland.
8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
9
New York State Psychiatric Institute, Vagelos College of Physicians & Surgeons of Columbia University, New York, New York.
10
Mayo Clinic's Evidence-Based Practice Center, Rochester, Minnesota.
11
NewYork-Presbyterian, Columbia University Medical Center, New York, New York.
12
University of Texas Southwestern Medical Center, Dallas, Texas.

Abstract

Objective:

To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010.

Conclusions:

The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.

PMID:
30272171
PMCID:
PMC6456929
DOI:
10.1210/jc.2018-01865
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center